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DNA ﬁ   ngerprinting data for 4,207 Mycobacterium tu-
berculosis isolates were combined with data from a com-
puter program (Origins). Largest population groups were 
from England (n = 1,031) and India (n = 912), and most 
prevalent strains were the Euro-American (45%) and East 
African–Indian (34%) lineages. Combining geographic and 
molecular data can enhance cluster investigation.
K
nowledge and understanding of transmission dynamics 
of Mycobacterium tuberculosis have been improved 
by development of rapid molecular techniques that are be-
ing more extensively applied (1–3). Globally, application 
of molecular techniques has identiﬁ  ed major M. tuberculo-
sis lineages associated with geographic origin (4–7). Previ-
ous studies on transmission dynamics of M. tuberculosis 
have usually analyzed patient-declared population groups 
to identify associations (1,7).
We describe a novel software (Origins; Experian, 
Nottingham, UK) that assigns cultural, ethnic, and lin-
guistic (CEL) groups on the basis of given and family 
names. Records from 12 countries containing 1,600,000 
family and 600,000 given names were analyzed to con-
struct >200 origin types based on CEL factors associ-
ated with given and family names. This approach is ap-
plicable worldwide and is more accurate and has better 
coverage than other software (8). The ﬁ  rst use of Origins 
in healthcare was identiﬁ  cation of how a European CEL 
group came to emergency departments in the United 
Kingdom (9).
The aim of this study was to combine mycobacterial 
ﬁ  ngerprinting data and patient origin as assigned by Ori-
gins to relate the occurrence of major global M. tubercu-
losis lineages in populations originating from around the 
world. Combining data obtained from universal typing 
and associated cultural and social links identiﬁ  ed by Ori-
gins provides the potential for a deeper understanding of 
the causes for distribution of prevalent strains in speciﬁ  c 
population groups.
The Study
Nonduplicate initial M. tuberculosis complex isolates 
(n = 4,207) were referred from the Midlands region of 
the United Kingdom (population 9.5 million) to our cen-
ter during January 2004–December 2007. These isolates 
were incubated, identiﬁ  ed, and analyzed by mycobacterial 
interspersed repetitive units containing variable numbers 
of tandem repeats (MIRU-VNTR) typing (10). MIRU-
VNTR typing analyzes the number of repetitive DNA se-
quences at multiple independent genetic loci. These data 
were compared with those in an online database (MIRU-
VNTRplus), which was developed by Allix-Beguec et 
al. (11). This database was used to assign M. tuberculo-
sis strains to 1 of 6 lineages: East African–Indian, East 
Asian, Euro-American, Indo-Oceanic, West African-1, or 
West African-2.
The given and family names of 4,207 patients were 
entered into Origins to obtain a CEL group for each, which 
was then assigned a continent on the basis of the United 
Nations Standard Country and Area Codes Classiﬁ  cation 
Scheme (12). Origins can assign a CEL group when the 
given and family names are present in a dataset.
Within the study population are predominant CEL 
groups that originate from each continent: 1,031 (25%) 
from England in Europe, 912 (22%) from India in Asia, and 
130 (3%) from Somalia in Africa (Table 1). The 18 isolates 
from the Americas represented 3 CEL groups. Origins as-
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Table 1. Mycobacterium tuberculosis isolates from CEL groups, 
the Midlands, UK*
Continent and CEL group   No. (%) isolates 
Africa 263 (6)
 Somalia  130  (3) 
  Other, n = 18 groups  133 (3) 
North and South America 
  CEL group, n = 3 groups  18 (0) 
Asia 2,421 (58) 
 India  912  (22) 
 Pakistan  777  (18) 
 Pakistan–Kashmir  212  (5) 
 Bangladesh  199  (5) 
  Northern India  95 (2) 
  Other, n = 22 groups  226 (5) 
Europe 1,473 (35) 
 England  1,031  (25) 
  Ireland   123 (3) 
 Scotland  99  (2) 
 Wales  98  (2) 
  Other, n = 23 groups  122 (3) 
Unclassified 32 (0)
Total 4,207 (100) 
*CEL, cultural, ethnic, and linguistic. CEL groups representing <1% (42 
isolates) of the total are not shown.  Global Origin of M. tuberculosis, UK
signed 4,175 (99%) of 4,207 patients to 77 CEL groups; 32 
patients were unclassiﬁ  ed.
Using the 15 MIRU-VNTR loci, we matched 4,117 
(98%) of 4,207 typed strains to strains in the MIRU-VN-
TRplus database. The 90 strains that did not match with 1 
of the 6 major global lineages were M. bovis (24 strains) or 
could not be deﬁ  nitively assigned (66 strains) to 1 of the 
6 global lineages. Continental and regional origins of pa-
tients as assigned by Origins and global lineage were then 
combined to identify the distribution of global M. tubercu-
losis lineages within each population (Table 2).
The Euro-American lineage was the most prevalent lin-
eage in our study. It contained 1,894 (45%) strains and was 
present in each continental human population group. The 
Euro-American strain was the most prevalent lineage in pa-
tients originating from Africa (125), the Americas (11), and 
Europe (1,072) and was the second most prevalent lineage 
in patients originating from Asia (663). The most prevalent 
M. tuberculosis lineage in patients originating from Asia 
was the East African–Indian lineage (1,150).
Combining geographic data assigned by Origins and 
DNA ﬁ  ngerprinting data could affect public health efforts 
to control tuberculosis because this approach can identify 
strains in CEL groups in which speciﬁ  c global M. tuber-
culosis lineages are not present. The MIRU-VNTR proﬁ  le 
424352332515333 (East Asian lineage) was identiﬁ  ed in 
23 patients from the Midlands. Of these 23 patients, 20 
resided within a 5-mile radius of each other. Within this 
geographically restricted cluster, 12 (60%) of these patients 
were assigned to the Europe CEL group and 8 patients to 
part of the Asia CEL group. The ﬁ  rst strain was identiﬁ  ed 
in 2004, and subsequent strains were identiﬁ  ed in each year 
of this study.
The MIRU-VNTR proﬁ  le 422352542517333 was iden-
tiﬁ  ed in 102 patients during 2004–2007. This proﬁ  le was 
matched with the East African–Indian lineage; 98 (96%) 
patients originated from Asia and 4 (4%) from Europe. This 
strain was identiﬁ  ed in various locations in the Midlands 
within an ≈40-mile radius that included all patients.
Conclusions
We studied >4,000 M. tuberculosis isolates typed in 
the United Kingdom. Our study demonstrated that the com-
bination of molecular and population group data provided 
by novel software can provide information about the mo-
lecular epidemiology of M. tuberculosis.
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Table 2. Distribution of Mycobacterium tuberculosis isolates according to lineage and continent of patient origin on the basis of CEL 
group, the Midlands, UK*  
No. (%) isolates in each M. tuberculosis lineage 
Continent and region 
East African–
Indian East Asian 
Euro-
American
Indo-
Oceanic
West
African-1
West
African-2
Total no. (%) 
isolates
Africa
  Eastern  56 (4)  9 (4)  62 (3)  39 (7)  0 0 166 (4) 
  Central  0 0 4 (0)  1 (0)  0 0 5 (0) 
  Northern  2 (0)  0 3 (0)  1 (0)  0 0 6 (0) 
  Southern  2 (0)  1 (0)  29 (2)  3 (1)  0 0 35 (1) 
  Western  5 (0)  3 (1)  21 (1)  5 (1)  4 (24)  1 (14)  39 (1) 
  Unknown  0 1 (0)  6 (0)  1 (0)  0 0 8 (0) 
  Region total  65 (5)  14 (6)  125 (7)  50 (9)  4 (24)  1 (14)  259 (6) 
Americas
  Caribbean region  2 (0)  0 5 (0)  0 0 0 7 (0) 
  North America  2 (0)  0 4 (0)  1 0 0 7 (0) 
  South America  2 (0)  0 2 (0)  0 0 0 4 (0) 
  Region total  6 (0)  0 11 (1)  1 (0)  0 0 18 (0) 
Asia
  Eastern  4 (0)  25 (11)  10 (1)  5 (1)  0 0 44 (1) 
  Southeastern  1 (0)  2 (1)  3 (0)  5 (1)  0 0 11 (0) 
  Southern  1,117 (79)  100 (46)  614 (32)  403 (72)  4 (24)  2 (29)  2,240 (55) 
  Western  5 (0)  0 13 (1)  1 (0)  0 0 19 (0) 
  Unknown  23 (2)  1 (0)  23 (1)  5 (1)  0 0 52 (1) 
  Region total  1,150 (81)  128 (59)  663 (35)  419 (75)  4 (24)  2 (29)  2,366 (58) 
Europe
  Eastern  1 (0)  1 (0)  17 (1)  2 (0)  0 0 21 (1) 
  Northern  186 (13)  69 (32)  994 (52)  74 (13)  7 (41)  4 (57)  1,334 (33) 
  Southern  9 (1)  6 (3)  40 (2)  6 (1)  1 (6)  0 62 (2) 
  Western  0 0 14 (1)  0 1 (6)  0 15 (0) 
  Unknown  1 (0)  0 7 (0)  2 (0)  0 0 10 (0) 
  Region total  197 (14)  76 (35)  1,072 (57)  84 (15)  9 (53)  4 (57)  1,442 (35) 
Unclassified  7 (0)  0 23 (1)  2 (0)  0 0 32 (1) 
Total 1,425 (100)  218 (100)  1,894 (100)  556 (100)  17 (100)  7 (100)  4,117 (100) 
*CEL, cultural, ethnic, and linguistic. Unknown indicates that the continent was identified but without a specific region. The United Kingdom (Great Britain 
and Northern Ireland) is located in northern Europe and India, Pakistan, and Bangladesh are located in southern Asia. A total of 90 (2%) of 4,207 strains 
were not assigned to 1 of the 6 major lineages. The 2 example MIRU-VNTR proﬁ  les show that mo-
lecular and social data identiﬁ  ed an East Asian strain in 
an unsuspected CEL group (Europe) and limited trans-
mission of an East African–Indian strain between CEL 
groups. Geographic restriction of the 424352332515333 
East Asian strain in the European CEL group identiﬁ  ed 
possible recent transmission within this population group. 
The 422352542517333 East African–Indian strain infected 
a large number of patients (102) and showed wide geo-
graphic spread with limited transmission into the European 
CEL group (4/102 patients). This ﬁ  nding indicates that this 
strain is widely distributed in southern Asia and has not 
been transmitted between CEL groups. Its wide distribu-
tion in the United Kingdom reﬂ  ects areas of residence for 
this CEL group.
Data from our study support previous ﬁ  ndings and ex-
tend the dataset for Europe. Our results also include a large 
number of strains from southern Asia, which were under-
represented in other studies (7,13).
Origins identiﬁ   ed CEL groups within a country 
(e.g., Kashmir in Pakistan or northern India) and divided 
Great Britain and Ireland into 4 CEL groups (Table 1). 
This enhanced differentiation could be useful in future 
population-based studies because migration patterns may 
be localized to speciﬁ  c areas within countries and com-
mon social networks could be identiﬁ  ed. CEL groups can 
be assigned to any dataset in which the patient’s name is 
known. Traditional epidemiologic identiﬁ  cation of ethnic 
groups requires a questionnaire, but if patient names are 
not in a dataset, then CEL groups cannot be assigned. Ori-
gins showed some discrepancies because the black Carib-
bean CEL group usually has British names and will be 
assigned as a British CEL group (8). However, the util-
ity of Origins is maximized when it is applied to diverse 
populations.
Many countries now routinely type M. tuberculo-
sis isolates by using MIRU-VNTR typing. This analysis 
identiﬁ  es clusters of strain types across place and time. By 
using Origin software for identiﬁ  cation of CEL groups, 
public health ofﬁ  cials can identify and investigate possible 
cultural links for transmission of M. tuberculosis.
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